Polaris Genomics

Biotechnology, 9841 Washingtonian BLVD, Gaithersburg, Maryland, 20878, United States, 1-10 Employees

Phone Number: +18*********

Who is POLARIS GENOMICS

The scope of experience of Polariss executive team spans nine decades & several fields, including military service, medicine, & federal research & development. These experiences have allo...

Get Full Access

Headquarters: 9841 Washingtonian BLVD, Gaithersburg, Maryland, 20878, United States
Date Founded: 2017
Employees: 1-10
Revenue: $1 Million to $5 Million
Active Tech Stack: See technologies
CEO: Charles Cathlin
- Email
- Phone

Industry: Biotechnology

SIC Code: 8071

Does something look wrong? Fix it. | View contact records from POLARIS GENOMICS

Polaris Genomics Org Chart and Mapping

Charles Cathlin

Chief Executive Officer

Email
Phone

Employees

Tshaka Cunningham

Chief Scientific Officer

Email
Phone

See Full Org Chart

View Email Formats for Polaris Genomics

You are signed out

Join Now

Free credits every month

Frequently Asked Questions Regarding Polaris Genomics

Answer: Polaris Genomics's headquarters are located at 9841 Washingtonian BLVD, Gaithersburg, Maryland, 20878, United States

Answer: The scope of experience of Polariss executive team spans nine decades & several fields, including military service, medicine, & federal research & development. These experiences have allowed the team to cultivate timely knowledge of pandemic-era mental health needs, & develop deeply unique qualifications to address these needs. The team has garnered numerous awards, ranks, titles, & accomplishments, ranging from captain to engineer, Purple Heart recipient to medical doctor, virologist & immunologist, 9/11 responder to Iraq War veteran, & PhD to Homeland Security Public Health Officer amid the threats of SARS & anthrax. In 2017, inspired by their work at the Defense & Veterans Brain Injury Center & the US Department of Veterans Affairs, a veteran & a scientist coalesced their visions seeded in service around the urgent need for 21st-century innovation in behavioral healthcare. Drawing upon decades of experience in biomedical technology, public health, & molecular biology, they founded a company to take aim at the mental health crisis that results in 22 veteran suicides each day. Partnering with the Illumina Accelerator & scientists from Mount Sinai & the Max Planck Institute of Psychiatry, the team developed the first-to-market, patented genomic biomarker assay to identify PTSD risk in 2018. As a veteran-owned business, our roots remain in our founding mission to improve the lives of US military service members & veterans living with behavioral health conditions, such as post-traumatic stress disorder (PTSD). In 2020, global public health events & an evolving behavioral health landscape revealed that the number of people standing to benefit from advances in diagnostics & treatment is broadening by the day. Guided by a calling to serve, we expanded our mission to encompass: - Veterans & active-duty US military service members, - First responders, frontline workers, & individuals in high-risk occupations, & - Trauma-exposed communities at large.